TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - TEVA PHARMACEUTICAL INDUSTRIES Share Price

Certificat

DE000SN5HUU2

Delayed Deutsche Boerse AG 11:20:13 18/07/2024 BST
8.4 EUR -1.64% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - TEVA PHARMACEUTICAL INDUSTRIES
1 month-9.34%
3 months+46.48%
Date Price Change
18/07/24 8.4 -1.64%
17/07/24 8.54 -2.95%
16/07/24 8.8 -3.61%
15/07/24 9.13 -2.25%
12/07/24 9.34 +0.43%

Delayed Quote Deutsche Boerse AG

Last update July 18, 2024 at 11:20 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Société Générale Société Générale
WKN SN5HUU
ISINDE000SN5HUU2
Date issued 12/07/2022
Strike 7.207 $
Maturity Unlimited
Parity 1 : 1
Emission price 0.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.75
Lowest since issue 0.71
Spread 0.21
Spread %2.44%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.38 USD
Average target price
18.94 USD
Spread / Average Target
+15.60%
Consensus